Patients with chronic lung infections, persistent cough, or suspected NTM disease, especially those immunocompromised, are recommended for this test.

Unlike culture, which takes weeks, HAINS NTM-DR provides faster results and detects drug resistance mutations directly.

Yes, identifying species and resistance mutations helps doctors select effective antibiotics and avoid ineffective therapies.

Positive results indicate NTM infections, which can cause chronic lung disease, skin infections, or disseminated disease in immunocompromised patients.

They cannot be fully prevented, but early detection and proper treatment reduce complications and disease progression.

Health care professionals may repeat the test if symptoms persist, worsen, or if treatment response needs monitoring.